Norway Cell Culture Market Size & Outlook, 2023-2030
Norway cell culture market, 2018-2030 (US$M)
Related Markets
Norway cell culture market highlights
- The Norway cell culture market generated a revenue of USD 170.3 million in 2023 and is expected to reach USD 317.5 million by 2030.
- The Norway market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cell culture market data book summary
| Market revenue in 2023 | USD 170.3 million |
| Market revenue in 2030 | USD 317.5 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, Corning Inc, Avantor Inc, BD, Eppendorf, Bio-Techne Corp, PromoCell GmbH |
Other key industry trends
- In terms of revenue, Norway accounted for 0.9% of the global cell culture market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK cell culture market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 2,552.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Market Scope
Cell Culture Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway cell culture market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 57.25% in 2023. Horizon Databook has segmented the Norway cell culture market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Norway has an advanced biotechnology industry, a favorable investment climate, supportive policies, and incentives for biotechnology & biopharmaceutical companies. The key players, such as Thermo Fisher Scientific, Eppendorf, and Merck KGaA, are present locally.
In addition, Norway’s well-developed infrastructure, including advanced laboratories, manufacturing facilities, and quality control systems, supports the life sciences industry. Furthermore, the presence of established scientific institutions & emerging innovators in the cell and gene therapy space is expected to support market growth over the forecast period.
For instance, in June 2020, Norway-based Zelluna Immunotherapy, a company specializing in T Cell Receptor (TCR) cell therapy, successfully concluded its fundraising efforts for advancing the development of its unique TCR-NK cell therapy platform for the treatment of various cancer types. These factors are indicative of the growth potential of the country in the biotechnology industry and can positively affect the cell culture market.
Reasons to subscribe to Norway cell culture market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway cell culture market databook
-
Our clientele includes a mix of cell culture market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway cell culture market , including forecasts for subscribers. This country databook contains high-level insights into Norway cell culture market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway cell culture market size, by product, 2018-2030 (US$M)
Norway Cell Culture Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
